Advertisement
Advertisement

ONCO

ONCO logo

Onconetix, Inc. Common Stock

4.72
USD
-1.57
-24.98%
Jun 13, 15:59 UTC -4
Closed
exchange

After-Market

4.78

+0.05
+1.06%

Onconetix, Inc. Common Stock Profile

About

Onconetix Inc. is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. Onconetix Inc., formerly known as Blue Water Biotech Inc., is based in CINCINNATI.

Info & Links

CEO

Karina Fedasz

Headquarters

201 East Fifth Street, Suite 1900
CINCINNATI, OH 45202, UNITED STATES

Sector

Medical

Auditor

MaloneBailey, LLP

Share holders

30

Employees

7

Onconetix, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

2.49M

Enterprise Value

9.87M

Enterprise Value/EBITDA(ttm)

-0.21

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

14.49

Price to Book(mrq)

0.08

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

44.50%

Operating Margin(ttm)

-1825.00%

Profit Margin(ttm)

-4173.59%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-517.95%

Return on Assets(ttm)

-48.09%

Income Statement

Revenue(ttm)

1.93M

Revenue Per Share(ttm)

0.04

Gross Profit(ttm)

911.90K

EBITDA(ttm)3

-46.38M

Net Income Available to Common(ttm)

-57.49M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

3.17

52-Week Change

-99.02%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

44.36M

Dividend Yield

0.00%

Float4

57.17M

% Held by Insiders

11.42%

% Held by Institutions

23.89%

Balance Sheet

Total Cash(mrq)

1.58M

Total Cash Per Share(mrq)

0.04

Total Debt(mrq)

8.96M

Total Debt/Equity(mrq)

224.31%

Current Ratio(mrq)

0.17%

Quick Ratio(mrq)

0.05%

Book Value Per Share(mrq)

0.11

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.11

Free Cash Flow(ytd)

-2.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement